Recently, broad immune profiling of MC38-OVA mice treated showed increased levels of NK cells and CD103+ dendritic cells after treatment with the small molecule A2AR inhibitor AZD4635 [11], implicating the NK-DC axis in the tumor-suppressing effects of A2AR inhibition. The gene discussed is ADORA2A; the disease is neoplasm.